ID   SDQLCHi014-A
AC   CVCL_YI67
DR   hPSCreg; SDQLCHi014-A
DR   Wikidata; Q98129475
RX   PubMed=31707215;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; 4599; GRM7; Unexplicit; Ex3-7del; Zygosity=Heterozygous; Note=De novo mutation (PubMed=31707215).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
RX   PubMed=31707215; DOI=10.1016/j.scr.2019.101635;
RA   Yang X.-M., Liu Y., Zhou T.-C., Zhang H.-Y., Dong R., Li Y., Liu N.,
RA   Liu Y., Gai Z.-T.;
RT   "An induced pluripotent stem cells line (SDQLCHi014-A) derived from
RT   urine cells of a patient with ASD and hyperactivity carrying a 303kb
RT   de novo deletion at chr3p26.1 implicating GRM7 gene.";
RL   Stem Cell Res. 41:101635-101635(2019).
//